The glucagon-like peptide-1 receptor (GLP-1R), a family B G-protein coupled receptor (GPCR), regulates the insulin secretion following stimulation by ligands. The transmembrane domain (TM) mediates GLP-1R homodimerization, which modulates its ligand binding and signaling. We investigated the possible involvement of the N-terminal extracellular domain (NTD) in dimerization/oligomerization and dimer-associated ligand binding by NanoLuc Binary Technology (NanoBiT). With improved NanoBiT detection using a decreasing substrate concentration, the negative cooperativity of ligand binding to the NTD was confirmed by accelerated dissociation and Scatchard analysis. The dimerization/oligomerization of the isolated NTD was observed by NanoBiT and validated by analytical ultracentrifugation, deriving the comparable dimerization affinity (~10 5 M −1 ). The NTD was also involved in the dimerization/oligomerization of the full-length GLP-1R with mutated TM4 at the cellular level. In an analysis of the parameters of the NTD binding, the K d for the probe GLP-1 (7-36, A8G) was similar (6-8 μM) in both the 1:1 binding model and the receptor dimerization model. Compared with GLP-1 and dulaglutide, exenatide showed two-site binding with K i values of 1.4 pM and 8.7 nM. Our study indicates the involvement of NTD in the GLP-1R dimerization/oligomerization and suggests that further investigations on the role in other family B GPCRs are needed.
| INTRODUCTION
Dimerization/oligomerization is widely observed for membrane receptors and plays a regulatory role in ligand binding and signaling. [1] [2] [3] The transmembrane domain (TM) was reported to be the main dimerization interface 4, 5 for most membrane receptors, including G protein-coupled receptors (GPCRs). A predominant role of the N-terminal extracellular domain (NTD) in dimerization was found for a few receptors, such as the insulin receptor family (disulfide bonds linked the NTD dimer), the receptor tyrosine kinases (RTKs), 6 and metabotropic glutamate receptor 5 (mGluR5), which is a member of family C GPCRs. 7 These receptors possess structurally complicated NTDs with high molecular weights (approximately 500-1000 amino acid residues).
The family B GPCRs are characterized by a large and unique NTD consisting of approximately 160 amino acids. 8 These receptor NTDs mediate the ligand recognition and binding as well as intracellular signaling for some wellknown endogenous hormones, such as secretin, parathyroid hormone, glucagon, and glucagon-like peptide-1. 9, 10 Homoand heterodimers are usually observed for the members of the family B GPCRs, 11 where the TMs rather than their NTDs provide the primary interfaces for their dimerization. 4, 12, 13 In the parathyroid hormone receptor (PTH1R), an exception among this family, NTD-mediated oligomerization has been demonstrated. 14 In addition, a motif on the NTD of pituitary adenylate cyclase activating polypeptide receptor (PAC1R) has also been reported to be crucial for dimerization. 15 Glucagon-like peptide-1 receptor (GLP-1R) is an established target for the treatment of type 2 diabetes and obesity. 16 GLP-1R-mediated signaling is modulated by its homodimerization and heterodimerization, in which TM4 is the dominant interface, similar to that of other family B GPCRs. [17] [18] [19] An earlier report 20 detected a dimer or oligomer form of the isolated NTD from GLP-1R, which was only observed for the glycosylated form. The possible cross-linking between the NTD in the non-glycosylated form was also mentioned by Bazarsuren et al. 21 Despite the contradictions, the results suggested that the isolated NTD may participate in the dimerization of GLP-1R.
Ligand binding induces receptor dimer or oligomer formation. 18, 22 Receptor dimerization could alter both the affinity and cooperativity of ligand binding. [23] [24] [25] Negative cooperativity of binding and its association with receptor dimerization/oligomerization are frequently reported for GPCRs from different classes. 23, 26, 27 These findings were also validated for the full-length GLP-1R by ligand accelerated dissociation, 11, 17 although a concave Scatchard curve in the ligand binding assay was not observed. 28 Both the ligand accelerated dissociation and the concave-up Scatchard curve are typical indices of the negative cooperativity originally described for insulin receptor binding. 29, 30 The NTD of GLP-1R (with or without a His-tag) has been assessed for ligand binding with radioisotope labeling, 20, [31] [32] [33] surface plasmon resonance (SPR) 21, 34 and isothermal titration calorimetry. 21 A lower affinity was observed for GLP-1 binding to the isolated NTD than to the full-length receptor, 20, 34 which was attributed to additional binding sites on the TMs, while no cooperativity in ligand binding was detected for the NTD.
NanoLuc Binary Technology (NanoBiT), 35 based on the engineered luciferase NanoLuc, 36 is a novel protein-fragment complementation technique. This method has been widely used to study the interactions between proteins, 37, 38 including receptor and ligand interactions. 39 Based on the ligand binding characterization of the GLP-1R NTD and the associated negative cooperativity, we were able to further identify the dimerization of the isolated NTD using an improved NanoBiT. This dimerization/oligomerization was verified by the biophysical characterization through analytical ultracentrifugation. The possible role of NTD in the dimerization of full-length GLP-1R was also revealed in cellular assays. all restriction enzymes were obtained from TaKaRa (Dalian, China). Pfu DNA polymerase and LA Taq DNA polymerase were obtained from Vigorous Biotechnology. Human SUMO1 cDNA was amplified from a plasmid 41 with the forward primer 5′-TATAGATCTGACCAGGAGGCAAAACCTTC-3′ and the reverse primer 5′-GCCCCCCGTTTGTTCCT GATAAAC-3′. A gene encoding GLP-1 (7-36, A8G) with a C-terminal linker 42 was amplified with the forward primer 5′-CAGGAACAAACGGGGGGCCACGGTGAAGGT ACCTTC-3′ and the reverse primer 5′-ATAGGATCCACC AC C G C CAC TAC CAC CAC CAC CAGA AC CAC CA CCACCAC-3′. The fused SUMO-GLP-1 gene was amplified by overlap PCR, digested with BamHI and BglII, and inserted into NLuc/pQE80L [encoding the N-terminal large fragment (LgBiT) of NanoLuc, a gift from Vigorous Biotechnology] at the BamHI site, yielding the plasmid for SUMO-L-LgBiT (L represents the ligand GLP-1). The hGLP-1R gene encoding the NTD was amplified with the forward primer 5′-TATGGATCCAGACCTCAGGGCGCTACC-3′ and the reverse primer 5′-TATAAGCTTAGTACAGAAA CAGCAGCTGTTC-3′ from a plasmid (GLP1-R/Tango, a gift from Dr Bryan Roth's Lab, Addgene plasmid # 66295). This product was digested with BamHI and HindIII and inserted into pQE80L (Qiagen, Hilden, Germany), resulting in a plasmid encoding a His-tag fused NTD (termed His R). An additional Tobacco Etch Virus (TEV) protease cleavage site was introduced after the His-tag by PCR with the forward primer 5′-CACGAAAACCTGTACTTC CAGGGATCCAGACCTCAGGGCGCTACCGTG-3′ and the reverse primer 5′-TCGCATCACCATCACCATCAC GAAAACCTGTACTTCCAGG-3′; this construct encodes His-TEV R, where the His-tag could be removed by TEV protease cleavage. A gene for a linker fusion to the C-terminal small fragment (SmBiT) of NanoLuc was synthesized using the following primers by PCR: f2 5′-GAACAGCTGCTGTTTCTGTACG GTGGCGGAGGTTCTGGAGGCGGTAG-3′, f1 5′-GCG GAGGTTCTGGAGGCGGTAGTGGCGGTGGTGG ATC-3′, r1 5′-CCTCGAACAGGCGGTAGCCGGTCAC GGATCCACCACCGCCACTACC-3′ and r2 5′-TATAAGCT TACAGGATCTCCTCGAACAGGCGGTAGCC-3′.
The product overlapped with that from hGLP-1R, and the amplified product was partially digested with BamHI and then completely digested with HindIII and inserted into pQE80L at the BamHI and HindIII sites. The obtained plasmid encodes His R-SmBiT. The BamHI-digested fragment from this plasmid was inserted into NLuc/pQE80L at the BamHI site, yielding the plasmid for His R-LgBiT. The plasmid encoding SUMO-R-SmBiT was constructed using the above plasmids.
GLP-1R/pcDNA3.1 was derived from GLP-1R/Tango by deleting all the inserted gene sequences other than hGLP-1R using PCR with the primers 5′-AGGCGTCCTGCTCTTAGCTC GAGTCTAGAGGGCCCGTTTAAACC-3′ and 5′-CCTCT AG AC T C G AG C TA AG AG C AG G AC G C C T G AC A AGTG-3′. The LgBiT or SmBiT gene was inserted at the C terminus of the hGLP-1R gene with a linker encoding GGGGSGGGSGGGGS by the sequence and ligation-independent cloning (SLIC) strategy, 43 thereby obtaining the constructs encoding GLP1R-LgBiT and GLP1R-SmBiT, respectively. The TM4 within GLP-1R was mutated using the primers f1 5′-TAATACGACTCACTATAGGG-3′, r1 5′-GCCCCAGGGGGCAACAAACGCCAGGGGAACAG CCCAGCCTATGCTCACG-3′; and f2 5′-GGCTGGGCTG TTCCCCTGGCGTTTGTTGCCCCCTGGGGCATT GTCAAGT-3′, r2 5′-TAGAAGGCACAGTCGAGG-3′, thereby creating the G252A, L256A, V259A mutations, with the constructed plasmids encoding the products termed mGLP-1R, mGLP1R-LgBiT and mGLP1R-SmBiT, respectively. All the plasmids were validated by sequencing (Taihe Biotechnology, Beijing, China). The amino acid sequences of the recombinant fusion products were predicted, and their theoretical molecular weights were calculated for the purpose of isolation and purification as listed in Table 1 .
| Preparation of recombinant proteins
The expression plasmids were transformed into Escherichia coli (E coli) strain BL21(DE3) pLysS, TG1 or TOP10. The overexpression was induced with IPTG (1 mM) at 25°C or 37°C overnight or 4 hours. Cells were harvested and lysed by freezing and thawing cycles in PBS with 1% Triton X-100 in the presence of approximately 0.5 mg/mL lysozyme. The lysed cells were forced through a syringe with a needle. The supernatants of soluble product (SUMO-GLP-1 fusion) were applied to Ni-IDA affinity chromatography for purification as instructed. The products in inclusion bodies (GLP-1R NTD fusions) were renatured as described 21 with a simplification. Briefly, inclusion bodies were dissolved in 20 mM Tris (pH 9.5), 6 M guanidine HCl, and 1 mM DTT and then diluted in refolding buffer (20 mM Tris pH 10.5, 0.5 M L -Arg, 1 mM GSH, 5 mM GSSG). Some of the products were purified by Ni-IDA affinity chromatography before renaturation. The fusions were either cleaved by ubiquitin-like-specific protease (Ulp) 1 or TEV protease (both expressed in E coli cells in our laboratory) for the SUMO-tag or His-tag, respectively, followed by chromatography for purification. The protein products were concentrated by salt or acid precipitation.
For the purification of the native NTD of GLP-1R (termed R), the TEV cleaved product was subjected to chromatography with the Äkta purifier FPLC system (GE Healthcare Bio-Sciences, Pittsburgh, PA, USA). The sample was applied to a HiTrap Q HP column (GE Healthcare Bio-Sciences) and eluted with linear concentrations of salt, and then applied to a HiTrap Phenyl HP column (GE Healthcare Bio-Sciences). A concentrated NTD monomer with high purity was collected. Note:
The amino acid residues of NanoLuc fragments are shown in italics. The sequences of GLP-1 (7-36, A8G, shown as a lowercase) and its receptor NTD are shown in bold. The cleavage site of Ulp 1 is indicated by the down arrows. The cleavage site of TEV protease is indicated by the up arrow.
| Protein quantification
Proteins were quantified by BCA kit (Thermo Scientific, Waltham, MA, USA) according to the manufacturer's instructions, or by measuring the absorbance at 280 nm on a UV-Vis Spectrophotometer SP-756PC (Shanghai Spectrum Instruments, Shanghai, China), with the concentrations determined using their molar extinction coefficients (listed in Table 1 ) predicted from the protein compositions (https :// web.expasy.org/protp aram/). The quantities of the fusion proteins were verified by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) using densitometric analysis as described 41 with QuantiScan Software (Biosoft, Cambridge, UK).
| NanoBiT-based binding assays
The binding of partners induces complementation of fused LgBiT and SmBiT, resulting in the recovery of luciferase activity. The probes fused separately to either SmBiT or LgBiT were incubated in binding buffer (1% BSA in PBS) for 40-60 minutes at room temperature. The substrate (10 μL furimazine) was added to the final concentration at the indicated dilution ratio at the beginning or end of the incubation. The luminescence indicating the recovered NanoLuc activity was measured in a total volume of 100 μL. A saturation assay was performed using low levels of SmBiT fusion (for ligand-receptor interaction) or LgBiT fusion protein (for receptor-receptor interaction) for binding with the respective partner at increasing concentrations as indicated. The luminescent intensities were measured. Similarly, in the competition assay, the binding of partners in fused with LgBiT and SmBiT was measured at equilibrium in the absence and presence of competitors at various concentrations as indicated. The dose-response of inhibition by the competitors was determined. The kinetics of binding was determined by continuously measuring the luminescence during association and dissociation. In the association assay, the binding was initiated by rapid mixing of the partners in 100 μL binding buffer in the presence of substrate (furimazine) at the indicated dilution ratio, with immediate measurement of the luminescence up to 20-40 minutes. The binding complex from preincubated partners at the indicated concentrations was subjected to a dissociation assay. Dissociation was initiated by the infinite dilution (100-to 5000-fold) and/or by adding the competitor at the indicated final concentration, in the presence of furimazine at the indicated dilution ratio, and the luminescence was monitored continuously for 30-60 minutes.
The receptor dimerization on the cells was evaluated via cellular assays in which the medium was removed and then 100 μL/well furimazine (1000-fold dilution in PBS) was added, incubated for ~5 minutes in the 96-well black/clear bottom plates, and then subjected to the luminescence detection. The co-transfected EGFP was also detected at the excitation wavelength of 488 nm and the emission wavelength of 520 nm.
All luminescence and fluorescence signals were assessed by an EnSpire multilabel reader (PerkinElmer Life and Analytical Sciences, Turku, Finland).
| Cell culture and transient transfection
The HEK 293ET (human embryonic kidney) cell line was bought from National Infrastructure of Cell Line Resources (Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, Beijing, China). The cell line was cultured in DMEM (Gibco, Life Technologies, Grand Island, NY, USA) supplemented with 10% (v/v) FBS (Livning, Beijing, China), 2 g/L NaHCO 3 and 100 units/mL of both penicillin and streptomycin. Twenty-four hours before transient transfection, the cells were plated in 96-well plates at 10 4 /well and cultured at 37°C in a humidified 5% CO 2 incubator. The cells were then transfected using VigoFect (Vigorous Biotechnology) according to the manufacturer's instructions. For the co-transfection, a constant 0.05 μg/ well pEGFP-N1 (Clontech Laboratories, Palo Alto, CA, USA) was applied as an internal reference and the total amount of plasmids was kept identical by supplementing appropriate amount of a plasmid pBlueScript SK + , with each plasmid used at various quantities as indicated. The cells were harvested or directly subjected to the NanoBiT assays after 48 hours. Each independent experiment was performed in triplicate wells.
Occasionally, the transfected cells were further incubated for 1 hour in the absence or presence of exenatide at the indicated concentrations.
| Analytical ultracentrifugation
Sedimentation velocity (SV) experiments were performed in a ProteomeLab XL-I analytical ultracentrifuge (Beckman Coulter, Brea, CA, USA) equipped with an AN-60Ti rotor (4-holes) and conventional double-sector aluminum centerpieces with 12 mm optical path length. Samples of 380 μL and buffer (PBS, pH 7.4) of 400 μL were loaded and centrifuged at a speed of 53 000 rpm at 20°C under continuous scan mode with radial spacing of 0.003 cm. Scans were collected in 3 minutes intervals at 280 nm. The fitting of absorbance versus cell radius data were performed using SEDFIT software (http://www.analy tical ultra centr ifuga tion.com/downl oad.htm) with the continuous sedimentation coefficient distribution [c(s)] model, covering a range of 0-15 S. The molecular weight of each peak was calculated with the best-fit friction ratio using the Svedberg equation.
Sedimentation equilibrium (SE) experiments were performed by loading protein samples (110 μL) and the reference buffer (120 μL) into a six-sector Epon charcoal-filled centerpiece at three concentrations (2.2 μM, 4.3 μM, 6.5 μM). Samples were spun at 8°C at speeds of 20 000, 31 000, and 40 000 rpm until sedimentation equilibrium was achieved as judged by the program SEDFIT. The data were analyzed using SEDPHAT software version 12.1b (http://www.analy tical ultra centr ifuga tion.com/sedph at/downl oad.htm) with a monomer-"m-mer"-"n-mer" self-association model, and the association constant (K a ) was estimated and dissociation constant (K d ) was calculated.
| Protein cross-linking
The purified His R-SmBiT (5 μM) with or without coincubation of L-LgBiT (20 μM in PBS, at room temperature for approximately 1 hour) was cross-linked with approximately 1.3 mM BS 3 . The reaction was stopped after 30 minutes incubation at room temperature by the addition of 1/20 volume of quenching buffer (1 M Tris-HCl, pH 7.5) with a further 15 minutes incubation. Samples were then analyzed by SDS-PAGE and Western blotting.
| SDS-PAGE and Western blotting
The recombined protein samples were directly mixed with Laemmli buffer. The cultured cells were lysed in RIPA buffer (ComWin Biotech, Beijing, China) and mixed with Laemmli buffer. With or without boiling for 5 minutes, the samples were subjected to SDS-PAGE as described by Laemmli 44 using 5% stacking gel with 13% or 15% separating gel. The gels were stained with Coomassie brilliant blue for direct visualization.
For Western blotting, the protein samples separated by SDS-PAGE were electroblotted to PVDF membranes (Millipore, Bedford, MA, USA). The membranes were blocked with 5% skim milk in PBST buffer (PBS-0.1% Tween 20) at room temperature for 3 hours and then incubated with the His-tag antibody (no. CW0286M, CWbio, Beijing, China), GLP-1R antibody (sc-390774, Santa Cruz Biotechnology, Dallas, TX, USA) or β-actin antibody (OriGene, Rockville, MD, USA) in 2.5% skim milk overnight at 4°C and then with the HRP-conjugated goat anti-mouse antibody (no. CW0102, CWbio) for 1.5 hours at room temperature. The target proteins were visualized with a chemiluminescence kit (Vigorous Biotechnology) using ImageQuant LAS 4000 ECL apparatus (GE Healthcare, Piscataway, NJ, USA) and quantified by their density in the exposed image using the QuantiScan software. The relative protein levels were calculated by normalizing to β-actin protein as the internal control. The ectopic GLP-1R expression level in the positively transfected 293ET cells was calculated by dividing the total expression by the transfection efficiency (the rate of EGFP-positive cells). The fresh INS-1 lysates (kindly provided by Professor Pingping Li of this Institute) were used as the control in the same immune-blots based on the assumption that the native GLP-1R was expressed at a physiological level in this rat pancreatic β-cell line.
| Data and statistical analysis
The data from ligand binding to GLP-1R NTD were all evaluated by the 1:1 binding model for the saturation, competition and kinetic assays, with the measured luminescence representing the binding as described. 35 The measured luminescence at the unsaturated substrate was used directly since it was proportional to that at saturated substrate according to the Michaelis-Menten equation
, when the substrate concentration is considered a constant. Dose-response curves from the ligand saturation assay were analyzed in GraphPad Prism 8 (GraphPad Software, Inc, La Jolla, CA, USA) with the total binding, nonspecific binding and specific binding fitted, and the dissociation constant (K d ) of the probe to the NTD was obtained. The saturated binding was also subjected to Scatchard analysis (specific binding luminescence/ligand concentration versus specific binding luminescence). Similarly, the dose-response curves of the competition assay were fitted, while the K i for the competitors were obtained not only from the one-site competition model but also from the two-site model if applicable. A Scatchard plot was applied to the competitors using a specific data transformation for the nonhomologous competition. 45 Because we used the total concentration of the competitors in substituting the free one in the analysis, the binding data were excluded at low concentrations (≤1 nM) due to possible depletion of the competitors. Kinetics in association and dissociation analyses was fitted by GraphPad Prism 8 according to one-phase exponential equations or to two-phase equations if applicable. A slight modification to the equation of association was used
, where the dead time (T 0 ) in the measurement was included for the estimation. The k off , k obs , k on and calculated K d (k off /k on ) were obtained.
The binding between two protomers of the receptor NTD was also analyzed based on the 1:1 monomer binding model for simplification. The apparent dissociation constant was obtained thermodynamically or kinetically.
The saturation and competition of ligand binding to NTD was further evaluated in a receptor dimer model, 46 which involved the allosteric interactions with receptor monomer and dimer.
The mechanism-based models were built using the dynamic biochemical interaction among receptor monomers, dimers and their ligands (detailed in Supplemental Figures S1, S2). The kinetics of receptor dimerization and the associated ligand binding was analyzed accordingly in the software COPASI 4.25 47 with various kinetic parameters obtained.
Data are presented as the mean ± SD of either averaged results of 2-4 independent experiments or the replicate determinations of a single typical experiment. One-way ANOVA (followed by Dunnett's multiple comparisons test) and Student's t test were performed using GraphPad Prism 8, and P values less than 0.05 were considered statistically significant.
| RESULTS

| Specific binding of the GLP-1R NTD to ligands under NanoBiT detection
NanoLuc Binary Technology (NanoBiT) detection was designed with GLP-1 (7-36, A8G) fused to LgBiT (termed L-LgBiT) and the NTD of GLP-1R fused to SmBiT (abbreviated as His R-SmBiT since it had a His-tag at the N-terminus) as the probes. The prokaryotically expressed proteins were purified and processed to obtain the desired probes (SDS-PAGE, embedded in Figure 1A , the molecular weights conformed to the theoretical values in Table 1 ). As expected, the combination of L-LgBiT and His R-SmBiT elicited a prominent luminescence signal ( Figure 1A) , indicating the association of the ligand with the NTD of GLP-1R.
The binding assays were performed in the initial presence of substrate to avoid the possible interference of dilution if the substrate was added at equilibrium. Furimazine at a saturated concentration (1:100 dilution, which denoted the concentration due to unrevealed information from the vendor) was used for enzymatic assays. 35 The saturation curves for L-LgBiT and His R-SmBiT were fitted according to a 1:1 binding model. The estimated dissociation constant (K d ) was 12.0 ± 2.8 μM, which is at least 10-fold higher than that using native GLP-1 in other studies by different methods. 32, 34 The ligand binding specificity was confirmed in competition assays ( Figure 1C ). Competitions by GLP-1 (7-36) and dulaglutide were well described with a one-site binding model with calculated K i values of 439 ± 144 nM and 13.6 ± 3.6 nM, respectively. The competitive curve for exenatide fitted well to the two-site binding model with K i values of 0.06 ± 0.08 nM for the high affinity site and 5.5 ± 2.5 nM for the low affinity site, while the fitted K i was 1.2 ± 0.1 nM in the one-site binding model.
A Scatchard plot was used to assess the negative cooperativity associated with the possible receptor dimer/oligomer. In the saturation binding of the probes, the Scatchard plot showed a curved but not straight line. This result implied possible cooperativity but in a positive way, contradicting the negative cooperativity observed for full-length GLP-1R. 17 Scatchard plots for the competitors were also derived ( Figure  1D ), which exhibited a typical concave-up shape for exenatide and dulaglutide but occasionally showed a straight line for GLP-1 . This result suggested negative cooperativity, at least for exenatide and dulaglutide binding, in the current assay.
The kinetics of association and dissociation between L-LgBiT and His R-SmBiT was monitored continuously at high concentrations of furimazine. The dissociation curve ( Figure 1E ) fitted well to the one-phase decay mechanism, with a k off value of 0.07 ± 0.006 min −1 . Data from association were also simulated well by the one-phase exponential kinetics. However, the estimated k on varied when different concentrations of L-LgBiT bound to His R-SmBiT ( Figure  1F ). Therefore, the K d calculated from k off /k on also varied (0.6-2.6 μM, Figure 1F ) and was lower than that from the saturation assay (12 μM).
| Impaired association/dissociation at a saturated furimazine concentration in NanoBiT assays
We wondered whether the decreased k on upon increased ligand concentrations ( Figure 1F ) was due to the variation in substrate depletion, which may also occur in the steadystate measurements. For verification, the association experiment was modified by the addition of an aliquot of substrate 20 minutes after the association initiated, either in the absence (blue line in the left panel of Figure 2A ) or presence (black line) of furimazine. A controlled association was initiated in the presence of substrate, with addition of an equal volume of buffer at 20 minutes (red line). An extra aliquot of substrate did not increase the luminescence intensity, indicating the saturation of furimazine at the recommended concentration. Surprisingly, a much higher luminescence was observed when the association was initiated without substrate, which was added 20 minutes later (blue line), than with substrate. Similarly, much lower luminescence was observed when an aliquot substrate was added 20 minutes after dissociation initiated, either in the absence (blue line in the left panel of Figure 2B ) or presence (black line) of furimazine, compared to that of the control (red line). A decrease rather than an increase in luminescence in dissociation was shown when an extra aliquot of substrate was added at 20 minutes (black line in the left panel of Figure  2B ). Therefore, in the presence of furimazine at the recommended concentration (at a dilution ratio of 1:100), both association and dissociation were kinetically interfered. At a low concentration of substrate (a dilution ratio of 1:500 in the middle panels of Figure 2A,B) , the discrepancy of luminescence in the absence (blue line) versus in the presence (red line) of the initial substrate was reduced in both association and dissociation assays and further reduced to a neglectable level at a dilution ratio of 1:2000 (red and blue , k obs and k on in (D)] were estimated by a 1:1 binding model, shown in the right panels as the mean ± SD for three independent experiments curves in the right panels of Figure 2A,B) . However, the chemiluminescent reaction occurred under an unsaturated condition at low concentrations of substrate (black lines in the middle and right panels of Figure 2A 
2C
). Similarly, the k obs and the k on values also increased upon further dilution in the association ( Figure 2D ). The rate constants of association/dissociation detected by NanoBiT would vary with the concentration of furimazine.
| Negative cooperativity in the binding of
GLP-1R NTD
We performed the receptor binding assays using NanoBiT with a low concentration of furimazine (with a dilution ratio of 1:2000) added at equilibrium because the substrate depletion was neglectable in our following detections (Supplemental Figure S3 ). The estimated K d (1.6 ± 0.1 μM) of L-LgBiT [GLP-1 (7-36), A8G] with the receptor NTD binding from the saturation curve ( Figure 3A) was an order of magnitude lower than that of the previous experiment ( Figure 1B ). This K d was slightly higher than that for native GLP-1 (7-36), 21, 31 which conformed to the discrepancy between these two forms of ligand binding to the full-length receptor. 48 The K i values [725 ± 151 nM for GLP-1 (7-36), 6.4 ± 0.3 nM for dulaglutide, and 1.2 ± 1.2 nM for exenatide] derived from the competition assay ( Figure 3B ) were similar to that from Figure 1C . Notably, a distinguished K i (0.9 ± 0.3 pM) for the high-affinity binding site of exenatide was determined, which was two orders of magnitude lower than the previous estimation above, whereas the K i (4.0 ± 1.0 nM) for the lowaffinity binding site was similar in the two-site competition model.
A decrease in luminescence for high L-LgBiT concentrations was observed after it plateaued at 20 μM ligand in the saturation assay ( Figure 3A ). This finding might indicate a negative cooperativity for the receptor NTD binding. For further verification of negative cooperativity, Scatchard analysis of saturated binding was performed. The results revealed straight lines but with the tail curved inward ( Figure   3A ) rather than concave-down curves as in the previous assay ( Figure 1B) . The Scatchard plots for the competitive binding of GLP-1 (7-36), dulaglutide and exenatide revealed concave-up curves ( Figure 3C ), as observed above, further supporting their negative cooperativity.
Negative cooperativity was further verified by the accelerated dissociation. The kinetics of dissociation ( Figure  3D ) and association ( Figure 3E ) under low furimazine (with a 1:2000 dilution ratio to eliminate interference from the substrate) showed slightly different kinetics from that observed at saturated furimazine ( Figure 1E,F) . The dissociation was obviously accelerated in the presence of different ligands ( Figure 3F ), while the dissociation kinetics initiated by 100-to 5000-fold dilution was perfectly identical. This acceleration was concentration-dependent, as shown for exenatide ( Figure 3G) , with the k off increasing at high concentrations. Accelerated dissociation was the pivotal criterion in defining the negative cooperativity of full-length GLP-1R. 11, 17 
| Validation of the self-association of
GLP-1R NTD
The possible dimer/oligomer form of GLP-1R NTD was examined because dimerization is closely related to negative cooperativity. The isolated His R-SmBiT was subjected to SDS-PAGE and Western blot analyses to identify these forms after cross-linking, as revealed previously. 20, 21 The bands corresponding to the monomers and dimers for this NTD in the absence or presence of ligand were clearly visualized, while the proportion of the dimer did not change by the addition of ligand ( Figure 4A,B) . Surprisingly, a significant amount of the dimer was observed (Figure 4A,B) by blotting the samples without cross-linking, although the dimer was not detected in SDS-PAGE ( Figure 4B ). The dimerization of the receptor F I G U R E 3 Evaluation of GLP-1R NTD binding to the ligands with improved NanoBiT. A, Saturated binding of L-LgBiT to His R-SmBiT (0.2 nM) was detected, with the specific binding was fitted to the 1:1 saturation model. The binding was also analyzed by a Scatchard plot (different symbols represent results from independent experiments). B, Competition of the binding of the probes (1 μM L-LgBiT, 0.5 nM His R-SmBiT) by GLP-1 (7-36), dulaglutide and exenatide was measured, with the curves fitted to a one-site binding model (solid lines) or a two-site competition model (for exenatide, in dotted line). The competition was analyzed by a Scatchard plot in (C) for each competitor, with different symbols representing results from independent experiments. D, Dissociation of prebound L-LgBiT (50 nM) and His R-SmBiT (50 nM) was initiated by excessive exenatide (100 μM). A one-phase decay model was used for curve fitting, and the k off was estimated as indicated. E, The monitored association of 0.5 nM His R-SmBiT with L-LgBiT at different concentrations was fitted to curves using a one-phase binding model. The k on was estimated, and K d was calculated as shown. F, The prebound complex from L-LgBiT (1 μM) and His R-SmBiT (10 μM) was subjected to dissociation by infinite dilution (1000-fold) in the absence or presence of different ligands, and the luminescence decay was recorded. The dissociation (the complex from 1 μM L-LgBiT and 1 μM His R-SmBiT) by infinite dilution (to different folds) without competitors was also measured as a control in the inset. G, Infinite dilution-induced dissociation in the presence of increasing concentrations of exenatide (from 0 to 20 μM) was detected and fitted to a one-phase decay model. The estimated k off values for different exenatide concentrations are displayed in the inset as the mean ± SD for the independent experiments. NanoBiT detection was performed at a low furimazine concentration (in a dilution ratio of 1:2000). The luminescence was measured immediately upon the addition of substrate at equilibrium of the binding or monitored continuously during kinetic processes. Each point in A and B represents the mean ± SD of three replicates. The typical results shown in A, B, D, E, F, and G were from three independent experiments NTD was validated by fragment complementation through its fusion to LgBiT and SmBiT. The homodimerization of the NTD was demonstrated by the concentration-dependent increase in luminescence ( Figure 4C ) with the coexistence of His R-LgBiT (identified in Supplemental Figure S4A) and
The characteristics of the receptor NTD dimerization were examined through the binding of His R-SmBiT with His R-LgBiT. Their binding was saturated at high concentrations but not in a monotonic manner ( Figure 4D ). This finding suggested a complicated binding mechanism at play, while the apparent K d of 94 ± 6 nM was estimated using the simple 1:1 saturation model. Concentration dependency was detected in the association ( Figure 4E ). The luminescence during dissociation increased rather than decayed continuously as expected ( Figure 4F ). These results indicated that a complicated mechanism was involved in this NTD dimerization. and His R-LgBiT (5 μM) was subjected to dissociation initiated by infinite dilution (100-fold). The kinetic parameters were fitted to the two-phase decay model, with a k fast and a k slow estimated as indicated. D, The kinetic association of R-SmBiT (1 μM) with His R-LgBiT (1 nM) was monitored continuously. The curve was fitted with a 1:1 binding model, with the k f estimated and K d calculated as shown. The luminescence was detected immediately upon the addition of substrate (in a dilution ratio of 1:2000) at equilibrium of the binding or the start of kinetic processes. The typical results from three independent experiments are shown in A, C and D. E, The purified native NTD without NanoBiT labeling (termed R, shown as the single band in both reduced and non-reduced SDS-PAGE in the inset) was subjected to the SV ultracentrifugation analysis. The c(s) distribution was illustrated for the sample at 23.7 μM, indicating the presence of the dimer and trimer in addition to the monomer, with their estimated molecular weights shown (in red). F, The purified R with three concentrations (from left to right panels) was analyzed by the SE at different speeds as indicated. The absorbance was recorded at the wavelength of 281 nm. The datasets were well fitted to the monomer-"m-mer"-"n-mer" selfassociation model by SEDPHAT, with the residuals of the fitting shown in the inset. The fitted K d was 4.5 and 26.9 μM for the monomer-dimer and monomer-trimer, respectively
| Characterization of the NTD dimerization in the absence of the Histag and the NanoBiT labels
The simple dimerization of the NTD may be complicated by the His-tag fused with the receptor, which could result in an extra interaction between the monomers. 49 The receptor NTD probe without a His-tag (termed R-SmBiT, identified in Supplemental Figure S4B ) was used for the examinations. Saturation was reached with increasing R-SmBiT binding with a small amount of His R-LgBiT ( Figure 5A ). The curve was fitted to a 1:1 binding model with an estimated apparent K d of 1.4 ± 0.3 μM, much greater than that for His R-SmBiT ( Figure 4D ). The Scatchard plot displayed straight lines ( Figure 5A ). This dimerization was measured in the presence of different ligands. Little difference was observed in the receptor dimerization at various concentrations of different ligands, which is similar to the observations via Western blotting ( Figure 4A,B) using the GLP-1 ligand probe. Surprisingly, a decreased interaction with the NTD was observed at increasing concentrations of exenatide, with a significant difference at 100 nM ( Figure 5B) .
When the kinetic process of dimerization was examined, a typical exponential decay of the luminescence was demonstrated in dissociation ( Figure 5C ). The data were fitted to a two-phase dissociation model with a fast dissociation rate constant (k fast ) and a slow one (k slow ) derived as indicated ( Figure 5C ). The binding luminescence during association ( Figure 5D ) was also assessed using a one-phase binding model, with a dimerization rate constant (k f ) estimated with k slow (the estimation failed using the k fast ). This apparent dissociation constant K d of the dimer was calculated as 0.7 ± 0.1 μM, slightly different from that derived from the saturation assay ( Figure 5A) .
A mechanism-based model was constructed for the receptor dimerization because it is involved in the reversible dimer formation of each NTD probe itself (illustrated in Figure 8A ). The binding reactions were entered into COPASI 47 (detailed in Supplemental Figure S1 ), and the luminescence during the association (Figures 4E and 5D ) was simulated with the mechanism-based model. The kinetic parameters for the dimerization of GLP-1R NTD with His-tag fusion (k f ' and k r ' for the association and dissociation rate, respectively) and that without a His-tag (similarly k f and k r ) were estimated (listed in Table 2 ). Since a global fit for the kinetics of Histagged NTD at various concentrations was unachievable, different parameters were derived individually (Supplemental Table S1 ). The NTD without the His-tag showed a 5-fold lower dissociation rate constant and a 1-fold higher association rate constant than the NTD with the His-tag at the lowest concentration. Therefore, the calculated K d was 9.8 μM for the NTD without the His-tag and 1.7 μM for the NTD with the His-tag. This difference was consistent with the discrepancy estimated from the saturated dimerization ( Figure  5A vs. Figure 4D ). His-tag fusion promoted receptor dimer formation.
The possible involvement of the NanoBiT labels in fusion with the NTD was also investigated, although a very low intrinsic affinity between the LgBiT and the SmBiT was reported (K d = 190 μM). 35 The native NTD was derived from the His-tagged protein ( His-TEV R in Table 1 ) by TEV protease cleavage followed by extensive purification procedures. The native R monomer substantially free of any dimer/trimers in the SDS-PAGE (inset of Figure 5E ) was subjected to an ultracentrifugation analysis. In the SV assay, peaks of 1.86 S, ~3 S, and ~4 S with calculated masses of 14.4, 29.7, and 45.6 kDa were observed, respectively ( Figure 5E ), and they corresponded to the predicted monomer, dimer, and trimer of R, respectively, indicating the self-association of the isolated native NTD. This self-association was further validated in SE studies at various concentrations of the native R ( Figure  5F ). The data were fitted to a monomer-"m-mer"-"n-mer" model, which was able to describe the dimerization and trimerization of the monomer. A K d of 4.5 μM was derived for the monomer-dimer conversion, while a K d of 26.9 μM was estimated for monomer-trimer conversion. These findings are generally consistent with the measured result (9.8 μM) in the NanoBiT assay, demonstrating the neglectable impact of the LgBiT or SmBiT fusion on the protomer interaction and measurement.
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| NTD mediated the dimerization of the full-length GLP-1R with the impaired transmembrane domain
Although the TM domain is well-known to direct oligomerization, we wondered whether the NTD within the intact GLP-1R participated in dimerization. The LgBiT and SmBiT were fused to the full-length GLP-1R without/ with the TM4 mutations (G252A, L256A, V259A, termed mGLP-1R) which disrupted the dimerization. 17 Coexpression of the wild-type GLP-1R probes provided significant luminescence in the NanoBiT assay (Supplemental Figure S5A ), indicating the dimerization of the full-length receptor on the membrane, which is similar to the results 11, 17 using the bioluminescence resonance energy transfer (BRET) assay. A dramatic decrease in luminescence was LgBiT fusion of the full-length GLP-1R, which carried mutations (G252A, L256A, V259A) that disrupted the TM4 domain, were transiently transfected into the 293ET cells with specified amounts for each set. The interaction between the receptors was determined by measuring the luminescence induced by fragment complementation. A constant amount of pEGFP-N1 was also co-transfected, and the fluorescence intensity of the co-expressed EGFP was used for the normalization of transfection efficiency. A, The luminescence from the transfection with either LgBiT fusion or SmBiT fusion was compared to that from the co-transfection of the both fusions, which is illustrated in the inset. The combination of equal amounts of both fusions were also compared at various quantities indicated below. Each bar represents the mean ± SD of four independent experiments, with * indicating P < .05 and ** indicating P < .01. B, The GLP-1R expression levels in the transiently transfected cells were determined by Western blotting using a monoclonal antibody against GLP-1R, with that from the INS-1 cells used as a control for the physiological expression level. The total expression (black bars) was calculated from immuno-staining (a typical result shown in the lower panel). The average GLP-1R expression (empty bars) in the EGFP-positive cells was calculated by dividing the positive rate and then assessed according to that in the INS-1 cells. The GLP-1R expression at the highest quantity of plasmids decreased rather than increased, possibly due to the cytotoxicity in the positively expressing cell. Each bar represents the mean ± SD of two among the four independent experiments in A. C, In the 293ET cells transiently transfected with 0.01 μg/well of each plasmid, the interaction between the TM4 mutated receptors was determined in the absence (as control) or presence of different concentrations of exenatide. The bars representing the relative luminescence was shown as the mean ± SD of four independent experiments. # P > .05, *P < .05, **P < .01 versus the control Figure S5A ), and it conformed to the disrupted function of TM4 as the oligomerization interface for GLP-1R. 17 Co-expression of the mGLP-1R probes yielded the increasing luminescence at higher amounts of plasmids ( Figure 6A ), and the luminescence of the probes was much higher than that of the background (inset in Figure 6A ), demonstrating the dimerization of the full-length receptors with the disrupted TM4. The GLP-1R expression levels in the transiently transfected cells were verified via comparison to that of the INS-1 cells (cultured rat pancreatic β-cells expressing GLP-1R) using Western blotting. The average expression levels of GLP-1R in the positively transfected cells were well below that of the INS-1 cells ( Figure 6B ), thereby ruling out a non-native oligomerization due to the ectopic expression of the receptors beyond the physiological level. The dimerization of the full-length receptors was inhibited in the presence of its ligand exenatide at higher concentrations, both for the wild-type (Supplemental Figure S5B ) and mutated GLP-1R ( Figure 6B ). This finding is strikingly similar to the observation in vitro of the isolated NTD in Figure 5B . The above results indicate that the NTD may play a role in mediating the dimerization of the full-length GLP-1R expressed in live cells when the TM4 interaction interface was disrupted.
| Assessment of ligand binding to the
GLP-1R NTD with reversible dimerization
Ligand binding was re-evaluated with this reversibly dimerized/trimerized NTD of GLP-1R. The binding of R-SmBiT reached saturation at 30 μM of L-LgBiT and gradually decreased at higher concentrations ( Figure 7A ). This finding was similar to the binding of His R-SmBiT ( Figure 3A) , while a 3-fold higher K d (6.6 ± 0.8 μM) was estimated for R-SmBiT by a 1:1 binding model. A similar straight line was also revealed in the Scatchard plot with an inward curved tail, similar to that for His R-SmBiT ( Figure 3A) . GLP-1 (7-36), dulaglutide and exenatide were effective in competition for R-SmBiT binding ( Figure 7B) , with K i values of 1.3 ± 0.09 μΜ, 22.5 ± 3.5 nM and 3.9 ± 0.9 nM, respectively, in a one-site competition model. The exenatide competition again showed a good fit for the two-site model, with a high affinity K i of 1.4 ± 0.3 pM and a low affinity value of 8.7 ± 1.3 nM. These dissociation constants were 1-to 2-fold higher than that for the receptor NTD with a His-tag. All their Scatchard plots displayed concave-up curves ( Figure 7C ), indicating negative cooperativity. The kinetics in dissociation ( Figure 7D ) and association ( Figure 7E ) of ligands for R-SmBiT was similar to that for His R-SmBiT. Accelerated dissociation was observed under different concentrations of exenatide (Figure F I G U R E 8 The basic reactions for the mechanism-based models. Receptor dimerization A, in the absence or B, in the presence of a probe ligand or C, with the competitor are illustrated, with R representing the NTD of GLP-1R, L representing the GLP-1 (7-36, A8G) and C representing the ligand competitor. The fused SmBiT and LgBiT are indicated by the small and large yellow tabs, respectively. The blue tab indicates the emitted luminescence from the complemented NanoLuc (yellow oval). The conversions between the species are denoted with dashed or solid arrows. The association and dissociation rates for the receptor NTD dimerization are indicated as k f and k r , while that for the NTD with His-tag are k f ' and k r ', respectively. k on and k off are the association and dissociation rates for site 1 binding of GLP-1R NTD, and k on ' and k off ' are those for site 2 binding. Similar parameters for the competitor binding with NTD are shown as k ion , k ioff and k ion ', k ioff ', respectively 7F,G), consistent with the negative cooperativity. These saturation and competition data were fitted to the receptor dimer models implicating the allosteric interactions with receptor monomer and dimer. 46 Unfortunately, meaningful fitness was unable to be obtained with the models using GraphPad Prism 8.
Therefore, a mechanism-based model (illustrated in Figure 8B ) for ligand binding to receptors involving NTD dimerization was constructed. The saturation data failed again in fitting to this model with COPASI. The luminescence during the association ( Figure 7E) was processed using the model to derive the rate constants (k off and k on ) for the ligand binding to site 1 on the receptor dimer as well as that (k off ' and k on ') for site 2, assuming that the empty dimer ligated a single ligand at site 1, while it bound the second ligand at site 2 for simplicity. Although the k off and k on values for site 1 were estimated (Table 2) , with the K d calculated as 8.4 ± 1.1 μM, we were unable to obtain the rate constants for site 2 with confidence in the estimations. Thus, the model for trimerization of the NTD was not constructed since it involved a more complicated binding mechanism with an extra site.
A modified model (illustrated in Figure 8C and detailed in Supplemental Figure S2 ) was established for binding in the presence of a competitor. This model was expected to obtain the dissociation rate constants for both sites because a distinguished site with a high dissociation rate was suggested in the accelerated dissociation ( Figure 7F ). Unfortunately, it was not capable of estimating the k off ' confidently for site 2 from these dissociation data, while the k off (0.12 ± 0.004 min −1 ) for site 1 was derived, being slightly lower than that obtained from the association ( Table 2 ).
| DISCUSSION
Similar to the findings of other members of family B GPCRs, the TM domain mediates the dimerization of GLP-1R, which plays a significant role in signaling. 11, 17 Here, the homodimerization/oligomerization of the isolated NTD of GLP-1R was revealed by NanoBiT in vitro and then validated with SV and SE assays. Furthermore, the involvement of NTD in the dimerization of full-length GLP-1R with disrupted TM4 was also demonstrated. This finding is not a surprise since a suspected dimer of the GLP-1R NTD was previously detected, 20,21 although the results were conflicting and were not further investigated. The involvement of the NTD in the dimerization of GPCR of this family was also reported for PTH1R 14 and PAC1R. 15 GLP-1 treatment was reported to have little effect on the homodimerization of the full-length GLP-1R in the cells using BRET. 18 Similarly, the proportion of the NTD homodimer was not affected by most of the ligands used ( Figure 5B ), although decreased dimer formation was observed in the presence of exenatide at high concentrations. Surprisingly, a decrease in dimerization at high concentrations of exenatide was also observed in the cellular NanoBiT assay for both the wild-type (Supplemental Figure  S5B ) and TM4 mutated ( Figure 6C ) GLP-1R. This result was inconsistent with the findings that most homodimers from the family B GPCRs were little affected by their ligands. 11 Based on previous results 13 as well as the results presented here, the participation of NTD was implied in the dimerization of the whole family B GPCRs.
We examined the kinetics of GLP-1R NTD dimerization using NanoBiT. The rate constants of association (k f ) and dissociation (k r ) were estimated to be 0.0059 ± 0.0015 μM −1 min −1 and 0.055 ± 0.004 min −1 , respectively. The calculated K d was 9.8 ± 2.7 μM, which is inconsistent with the measurement via analytical ultracentrifugation (K d of 4.5 and 26.9 μM for monomer-dimer and monomer-trimer, respectively). The dimerization of GPCR is usually analyzed by BRET on the membrane of the transfected cells. 18, 24 The affinity reported for GLP-1R and secretin receptor dimerization was indexed as relative quantities rather than in a universal or comparable unit. 19 The epidermal growth factor receptor (EGFR) dimerization is the critical event in its activation, which is mediated predominantly by the extracellular domain. 50 The EGF-induced dimerization of the soluble extracellular domain of EGFR had a value of 2.4 μM. 51 Thus, the GLP-1R NTD would have a nonnegligible if not substantial contribution to the receptor dimerization under physiological conditions, which is supported by the cellular experiment showing that the NTD was involved in the dimerization of full-length GLP-1R with disrupted TM4.
The dimerization/oligomerization of receptors usually results in negative cooperativity of ligand binding. 24, 25 The accelerated dissociation of the probe from the NTD of GLP-1R in the presence of different ligands was demonstrated, providing typical evidence for its negative cooperativity. An accelerated dissociation also validated the negative cooperativity for the full-length GLP-1R. 11, 17 When the dimerization was disrupted by the TM4 mutations, the accelerated dissociation was impaired but not completely eliminated [ Figure S3 in reference 17].
The Scatchard plot for the full-length GLP-1R binding displayed a straight line using a radioisotope labelled probe. 28 A straight line was also observed for GLP-1R NTD in the Scatchard analysis for our saturation assay using NanoBiT, although with the tail curved inward ( Figures 3A and 7A ). Supporting the negative cooperativity, the Scatchard plots for GLP-1 (7-36), dulaglutide and specifically exenatide from competitive binding were concave-up curves ( Figure 7C ). In fact, the Scatchard curves for GLP-1 (7-36) and dulaglutide displayed a straight line in the range outside the highest binding point, suggesting the lack of cooperativity at low concentrations.
